Emily Bernstein, PhD

Emily Bernstein, PhD, is Professor and Vice Chair of the Department of Oncological Sciences at the Icahn School of Medicine at Mount Sinai. Dr. Bernstein is also Co-leader of the Cancer Mechanisms Research Program at The Tisch Cancer Institute. As such, Dr. Bernstein facilitates basic research on genetic, epigenetic, biochemical, and developmental pathways that drive cancer initiation and progression, and fosters intra- and inter-program collaborations that accelerate the development of novel, targeted therapies for cancer.

Dr. Bernstein’s laboratory studies the epigenetic regulation of gene expression in cancer and development, with the long-term goal of understanding the chromatin changes that take place at the molecular level during the transformation process of normal cells to cancer cells. Her team studies melanoma skin cancer, and pediatric cancers such as neuroblastoma.

Dr. Bernstein teaches courses on cancer biology and serves on numerous PhD thesis committees at the Icahn School of Medicine at Mount Sinai. She served as a member of the Cancer Genetics Study Section of the NIH Center for Scientific Review, serves as a standing reviewer for multiple research grant foundations and is an Associate Editor for the journal Science Advances.

Bernstein Laboratory